Bradykinin-Induced Dilation of Human Coronary Arterioles Requires NADPH Oxidase–Derived Reactive Oxygen Species

Objective—Hydrogen peroxide (H2O2) is an endothelium-derived hyperpolarizing factor in human coronary arterioles (HCAs). H2O2 mediates bradykinin (BK)-induced vasodilation and reduces bioavailability of epoxyeicosatrienoic acids (EETs); however, the cellular and enzymatic source of H2O2 is unknown. Methods and Results—NADPH oxidase expression was determined by immunohistochemistry. Superoxide and H2O2 production was assayed in HCAs and human coronary artery endothelial cells (HCAECs) using dihydroethidium and dichlorodihydrofluorescein histofluorescence, respectively. Superoxide was quantified by HPLC separation of dihydroethidium products. Diameter changes of HCAs were measured by videomicroscopy. NADPH oxidase subunits Nox1, Nox2, Nox4, p22, p47, and p67 were each expressed in HCA endothelium. In HCAs or HCAECs incubated with dihydroethidium and dichlorodihydrofluorescein, BK induced superoxide and H2O2 formation, which was inhibited by gp91ds-tat or apocynin but not by gp91scram-tat or rotenone. HPLC analysis confirmed that BK specifically induced superoxide production. Gp91ds-tat reduced vasodilation to BK but not to papaverine. 14,15-EEZE (an EET antagonist) further reduced the residual dilation to BK in the presence of gp91ds-tat, but had no effect in the presence of gp91scram-tat, suggesting that NADPH oxidase–derived ROS modulate EET bioavailability. Conclusion—We conclude that endothelial NADPH oxidase is a functionally relevant source of H2O2 that mediates agonist-induced dilation in the human heart.

[1]  H. Miura,et al.  Hydrogen Peroxide Inhibits Cytochrome P450 Epoxygenases: Interaction Between Two Endothelium-Derived Hyperpolarizing Factors , 2008, Circulation research.

[2]  W. Campbell,et al.  Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. , 2007, Trends in pharmacological sciences.

[3]  H. Jo,et al.  Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. , 2006, Antioxidants & redox signaling.

[4]  H. Miura,et al.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition. , 2006, American journal of physiology. Heart and circulatory physiology.

[5]  M. Dinauer,et al.  Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. , 2006, Cellular signalling.

[6]  H. Cai.  Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. , 2005, Cardiovascular research.

[7]  L. Kuo,et al.  C-Reactive Protein Inhibits Endothelium-Dependent NO-Mediated Dilation in Coronary Arterioles by Activating p38 Kinase and NAD(P)H Oxidase , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Hongtao Zhao,et al.  Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Nicolosi,et al.  Mitochondrial Sources of H2O2 Generation Play a Key Role in Flow-Mediated Dilation in Human Coronary Resistance Arteries , 2003, Circulation research.

[10]  D. Harrison,et al.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. , 2003, Trends in pharmacological sciences.

[11]  R. Clempus,et al.  Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  Hiroaki Shimokawa,et al.  Electron Spin Resonance Detection of Hydrogen Peroxide as an Endothelium-Derived Hyperpolarizing Factor in Porcine Coronary Microvessels , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Hongtao Zhao,et al.  Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. , 2003, Free radical biology & medicine.

[14]  D. Harrison,et al.  Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[15]  A. Nicolosi,et al.  Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels , 2003, Circulation research.

[16]  Takashi Saito,et al.  Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.

[17]  K. Griendling,et al.  NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. , 2002, Antioxidants & redox signaling.

[18]  A. Dominiczak,et al.  NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels , 2002, Hypertension.

[19]  W. Zidek,et al.  Captopril and quinapril reduce reactive oxygen species , 2002, European journal of clinical investigation.

[20]  J. Falck,et al.  14,15-Epoxyeicosa-5(Z)-enoic Acid: A Selective Epoxyeicosatrienoic Acid Antagonist That Inhibits Endothelium-Dependent Hyperpolarization and Relaxation in Coronary Arteries , 2002, Circulation research.

[21]  L. Mazzolai,et al.  Flow Pulsatility Is a Critical Determinant of Oxidative Stress in Endothelial Cells , 2001, Hypertension.

[22]  F. Rey,et al.  Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2− and Systolic Blood Pressure in Mice , 2001, Circulation research.

[23]  Takashi Saito,et al.  Flow-Induced Dilation of Human Coronary Arterioles: Important Role of Ca2+-Activated K+ Channels , 2001, Circulation.

[24]  R. Busse,et al.  Endothelium-Derived Hyperpolarizing Factor Synthase (Cytochrome P450 2C9) Is a Functionally Significant Source of Reactive Oxygen Species in Coronary Arteries , 2001, Circulation research.

[25]  Takashi Saito,et al.  Flow-Induced Dilation of Human Coronary Arterioles , 2001 .

[26]  H Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.

[27]  H. Miura,et al.  Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels. , 2000, American journal of physiology. Heart and circulatory physiology.

[28]  R. Busse,et al.  Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. , 2000, Hypertension.

[29]  H. Miura,et al.  Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. , 1999, Circulation.

[30]  H. Miura,et al.  Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. , 1998, Circulation research.

[31]  D. Gutterman,et al.  Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. , 1998, Cardiovascular research.

[32]  N. Glorioso,et al.  Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. , 1997, Circulation.

[33]  M. Ushio-Fukai,et al.  p22phox Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.

[34]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[35]  T. Unger,et al.  Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. , 1995, Pharmacological reviews.